Patents Represented by Attorney Kalow & Springut LLP

Find this attorney in the Justia Lawyer Directory

  • Process and apparatus for catalytic conversion of hydrocarbons for generating a gas rich in hydrogen
    Patent number: 7700070
    Abstract: The present invention relates to the catalytic conversion of hydrocarbons for generating a gas that is rich in hydrogen, to the use of said apparatus and to a process for generating hydrogen. The apparatus comprises a reforming catalyst (5), as well as a means (8) for supplying hydrocarbons to the catalyst. The reforming catalyst is arranged in an exhaust pipe (3) through which the exhaust gases of combustion processes are passed.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: April 20, 2010
    Assignee: Umicore AG & Co. KG
    Inventors: Hartmut Finkbeiner, Jürgen Gieshoff
  • siRNA targeting complement factor B
    Patent number: 7696344
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: April 13, 2010
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Stephen Scaringe, Steven Read
  • siRNA targeting nucleoporin 62kDa (Nup62)
    Patent number: 7691998
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for Nup62.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: April 6, 2010
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • Functional and hyperfunctional siRNA
    Patent number: 7691997
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: April 6, 2010
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Stephen Scaringe, Steven Read
  • siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)
    Patent number: 7678896
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to STK12.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: March 16, 2010
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • siRNA targeting BCL2L1
    Patent number: 7674896
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: March 9, 2010
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Stephen Scaringe, Steven Read
  • Use of a phosphorus containing ligand and a cyclic organic ligand in a transition metal compound
    Patent number: 7671224
    Abstract: According to the present invention there is provided a compound in the form of a transition metal compound including a transition metal, a phosphorus containing ligand, and a cyclic organic ligand. The phosphorus containing ligand is a heterocyclic organic compound with a ligating phosphorus atom which ligates with the transition metal, and which ligating phosphorus atom is an atom in the heterocyclic ring structure of the heterocyclic organic compound. The cyclic organic ligand is a cyclic organic compound with a ligating carbon atom in the cyclic ring structure of the cyclic organic compound which ligates with the transition metal by means of a double bound. The invention also relates to a method preparing such a compound and a metathesis reaction wherein such a compound is used as a catalyst.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: March 2, 2010
    Assignee: Umicore AG & Co. KG
    Inventors: Roland Winde, Ralf Wilhelm Karch, Andreas Rivas-Nass, Oliver Briel, Robert Paul Tooze, Grant Stephen Forman, Wolfgang Hubert Meyer
  • siRNA targeting connective tissue growth factor (CTGF)
    Patent number: 7666853
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CTGF.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: February 23, 2010
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • siRNA targeting myeloid differentiation primary response gene (88) (MYD88)
    Patent number: 7662950
    Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for MYD88.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: February 16, 2010
    Assignee: Dharmacon, Inc.
    Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
  • System and method for confirming specification of intended electronic mail message recipients
    Patent number: 7660854
    Abstract: New and improved systems and methods for confirming transmission of email and other similar messages (e.g., instant messages, wireless device messages, etc.). Such systems and methods includes and involve generation means for permitting a sender to generate an email message to be sent to a specified recipient via a messaging system, confirmation means for confirming that the email message is to be sent to the specified recipient by presenting to the sender a confirmation notice requesting the sender to confirm that the specified recipient is an intended recipient of the email message, and sending means for causing the email message to be sent to the specified recipient via the messaging system after the sender operates the confirmation means and confirms that the specified recipient is an intended recipient.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: February 9, 2010
    Inventor: Michoel Sorotzkin
  • Watch dial
    Patent number: D609128
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: February 2, 2010
    Assignee: Cartier Creation Studio SA
    Inventor: Serge Rabassa
  • Perfume bottle with cap
    Patent number: D610013
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: February 16, 2010
    Assignee: FD Management, Inc.
    Inventor: Cheryl Mendelson
  • Drain unclogger
    Patent number: D610761
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: February 23, 2010
    Inventors: Charles Gengler, Robert Petner
  • Ring
    Patent number: D611870
    Type: Grant
    Filed: June 22, 2009
    Date of Patent: March 16, 2010
    Assignee: Montblanc-Simplo GmbH
    Inventor: Dalia Greppi
  • Docking station
    Patent number: D611931
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: March 16, 2010
    Assignee: Coby Electronics Corporation
    Inventor: Johann Lee
  • Spectacles
    Patent number: D611982
    Type: Grant
    Filed: April 24, 2009
    Date of Patent: March 16, 2010
    Assignee: Cartier Creation Studio SA
    Inventor: Jean Mouclier
  • Writing instrument
    Patent number: D611987
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: March 16, 2010
    Assignee: Cartier Creation Studio S.A.
    Inventor: Jean Mouclier
  • Bracelet
    Patent number: D612282
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: March 23, 2010
    Assignee: Cartier Creation Studio SA
    Inventor: Luca Iacomucci
  • Ring
    Patent number: D612284
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: March 23, 2010
    Assignee: Cartier Creation Studio SA
    Inventor: Luca Iacomucci
  • Watch
    Patent number: D613622
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: April 13, 2010
    Assignee: Cartier Creation Studio SA
    Inventor: Arnaud Chastaingt